Srivastava et al. identified higher serum levels of VEGF-A in patients with HNSCC compared to the control group but also in patients with more advanced stages of the disease (stages III and IV) compared to patients with tumors in stages I and II [42]. The gene discussed is VEGFA; the disease is head and neck squamous cell carcinoma.